Aarti Drugs Limited — Call Transcript 2023

Jan 25, 2023

==> picture [512 x 106] intentionally omitted <==

Ref: ADL/SE/2022-23/93 January 25, 2023

To, To, Listing/ Compliance Department Listing/ Compliance Department BSE Limited National Stock Exchange of India Phiroze Jeejeebhoy Towers, Limited, Dalal Street, “Exchange Plaza”, Bandra - Kurla Complex, Mumbai – 400 001 Bandra (E), Mumbai – 400051 NSE SYMBOL: AARTIDRUGS BSE CODE – 524348

Dear Sir/Madam,

Ref : Regulation 30(6) of SEBI (LODR) Regulations, 2015 Sub: Intimation of Conference Call

This is to inform you that Quarterly Conference Call for the Investors and Analysts has been scheduled on Monday, January 30, 2023 at 03:30 P.M. IST to discuss the Company’s financial performance for the Quarter and nine months ended December 31, 2022. Please find attached herewith invitation for the same.

Kindly take the same on record.

Thanking you,

Yours faithfully,

FOR AARTI DRUGS LIMITED

RUSHIKESH VIVEK DEOLE Digitally signed by RUSHIKESH VIVEK DEOLE DN: c=IN, o=PERSONAL, title=5599, pseudonym=52288d43536c4230831c2e75cd4b8c59, 2.5.4.20=073813c4edff683f8b6ec3cb4e69ca6d8d4f7258a44f635abc18581eaa522821, postalCode=421301, st=Maharashtra, serialNumber=9b60f64457feab7f455d17463ebe710861bf01b575f6fc0484483273dabfc17f, cn=RUSHIKESH VIVEK DEOLE Date: 2023.01.25 20:43:01 +05'30'

RUSHIKESH DEOLE COMPANY SECRETARY & COMPLIANCE OFFICER ICSI M.No.: A54527

==> picture [468 x 29] intentionally omitted <==

==> picture [117 x 54] intentionally omitted <==

Aarti Drugs Limited

Cordially invites you to

Conference Call

To discuss the financial performance for the Quarter and Nine-month ended 31[st] December, 2022

Day/Date : Monday, 30[th] January, 2023 Time : 03:30 PM, IST

Diamond Pass : Please Click here to express join the Call

Primary Number:	+91 226280 1309
	+91 22 7115 8210
Toll Free Number:	Hongkong– 800964448
	Singapore– 8001012045
	UK– 08081011573
	US– 18667462133

Participants:

Mr. Harshit Savla – Jt. Managing Director Mr. Harit Shah – Wholetime Director

Mr. Adhish Patil – Chief Finance Officer

Mr. Vishwa Savla – Managing Director, Pinnacle Life Science Private Limited

We look forward to your participation

RSVP

Jigar Kavaiya / Chinmay Madgulkar, Strategic Growth Advisors Pvt. Ltd., Contact: +91 99206 02034/ 98600 88296